Astrana outlines $3.8B-$4.1B 2026 revenue outlook as net leverage targets at or below 2x

Taiwan Semi, Sony plan to form joint venture for image sensors

Guardant Health raises 2026 revenue outlook to $1.30B-$1.32B as Shield targets 230,000-245,000 tests

Organogenesis forecasts $270M-$310M 2026 revenue amid prolonged CMS-related recovery

‘Americans love their rose-colored glasses’: I was a slave to credit-card debt, then I got laid off and turned my life around